Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

per Gori, Stefania, Clavarezza, Matteo, Siena, Salvatore, Foglietta, Jennifer, Tarenzi, Emiliana, Giordano, Monica, Molino, Annamaria, Graiff, Claudio, Fusco, Vittorio, Alabiso, Oscar, Baldini, Editta, Gamucci, Teresa, Altavilla, Giuseppe, Dondi, Davide, Venturini, Marco
Publicat 2012

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

per Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Caserta, Claudia, Fabi, Alessandra, Clavarezza, Matteo, Maiello, Evaristo, Eoli, Marica, Lombardi, Giuseppe, Monteforte, Marta, Proietti, Emanuela, Agati, Raffaele, Eusebi, Vincenzo, Franceschi, Enrico
Publicat a Neuro Oncol (2016)

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

per Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Fabi, Alessandra, Caserta, Claudia, Tosoni, Alicia, Eoli, Marica, Lombardi, Giuseppe, Clavarezza, Matteo, Paccapelo, Alexandro, Bartolini, Stefania, Cirillo, Luigi, Agati, Raffaele, Franceschi, Enrico
Publicat a Oncotarget (2017)

Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study

per Clavarezza, Matteo, Bordonaro, Roberto, Daniele, Bruno, Ferrandina, Gabriella, Barni, Sandro, Turazza, Monica, Coati, Francesca, De Matteis, Andrea, De Placido, Sabino, Cognetti, Francesco, Olmeo, Nina Antonina, Carrozza, Francesco, Bruzzi, Paolo, Del Mastrol, Lucia
Publicat 2013

Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study

per Clavarezza, Matteo, Bordonaro, Roberto, Daniele, Bruno, Ferrandina, Gabriella, Barni, Sandro, Turazza, Monica, Coati, Francesca, De Matteis, Andrea, De Placido, Sabino, Cognetti, Francesco, Olmeo, Nina Antonina, Carrozza, Francesco, Bruzzi, Paolo, Del Mastro, Lucia
Publicat 2013

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study

per Clavarezza, Matteo, Mustacchi, Giorgio, Casadei Gardini, Andrea, Del Mastro, Lucia, De Matteis, Andrea, Riccardi, Ferdinando, Adamo, Vincenzo, Aitini, Enrico, Amoroso, Domenico, Marchetti, Paolo, Gori, Stefania, Carrozza, Francesco, Maiello, Evaristo, Giotta, Francesco, Dondi, Davide, Venturini, Marco
Publicat 2012

AT-11 FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM

per Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Fabi, Alessandra, Caserta, Claudia, Clavarezza, Matteo, Maiello, Evaristo, Cartenì, Giacomo, Rosti, Giovanni, Eoli, Marica, Lombardi, Giuseppe, Monteforte, Marta, Agati, Raffaele, Eusebi, Vincenzo, Galli, Anna, Doria, Simona, Franceschi, Enrico
Publicat 2014

NI-26 COMPARATIVE ANALYSIS OF THE RANO AND MACDONAD'S CRITERIA IN RECURRENT GLIOBLASTOMA TREATED IN THE RANDOMIZED PHASE II TRIAL AVAREG WITH BEVACIZUMAB OR FOTEMUSTINE.

per Franceschi, Enrico, Agati, Raffaele, Finocchiaro, Gaetano, Zagonel, Vittorina, Fabi, Alessandra, Reni, Michele, Caserta, Claudia, Maiello, Evaristo, Cartenì, Giacomo, Clavarezza, Matteo, Rosti, Giovanni, Eoli, Marica, Lombardi, Giuseppe, Bacci, Antonella, Monteforte, Marta, Doria, Simona, Galli, Anna, Brandes, Alba A.
Publicat 2014

The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin...

per Petrera, Marilena, Paleari, Laura, Clavarezza, Matteo, Puntoni, Matteo, Caviglia, Silvia, Briata, Irene Maria, Oppezzi, Massimo, Mislej, Eva Mihajlovic, Stabuc, Borut, Gnant, Michael, Bachleitner-Hofmann, Thomas, Roth, Wilfried, Scherer, Dominique, Haefeli, Walter-E., Ulrich, Cornelia M., DeCensi, Andrea
Publicat a BMC Cancer (2018)

Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer

per Campora, Sara, Campazzi, Eleonora, Zanardi, Silvia, Puntoni, Matteo, Piccininno, Marco, Piccardo, Arnoldo, Shoushtari Zadeh Naseri, Mehrdad, Defferrari, Carlotta, Provinciali, Nicoletta, Petrera, Marilena, Marra, Domenico, Biscaldi, Ennio, Antonucci, Gian Carlo, Ricci, Damiano, Clavarezza, Matteo, Gennari, Alessandra, Gozza, Alberto, D'Amico, Mauro, Mori, Marco, DeCensi, Andrea
Publicat a Transl Oncol (2016)

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

per Morano, Federica, Corallo, Salvatore, Lonardi, Sara, Raimondi, Alessandra, Cremolini, Chiara, Rimassa, Lorenza, Murialdo, Roberto, Zaniboni, Alberto, Sartore-Bianchi, Andrea, Tomasello, Gianluca, Racca, Patrizia, Clavarezza, Matteo, Adamo, Vincenzo, Perrone, Federica, Gloghini, Annunziata, Tamborini, Elena, Busico, Adele, Martinetti, Antonia, Palermo, Federica, Loupakis, Fotios, Milione, Massimo, Fucà, Giovanni, Di Bartolomeo, Maria, de Braud, Filippo, Pietrantonio, Filippo
Publicat a J Clin Oncol (2019)

Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Tr...

per Pietrantonio, Filippo, Morano, Federica, Corallo, Salvatore, Miceli, Rosalba, Lonardi, Sara, Raimondi, Alessandra, Cremolini, Chiara, Rimassa, Lorenza, Bergamo, Francesca, Sartore-Bianchi, Andrea, Tampellini, Marco, Racca, Patrizia, Clavarezza, Matteo, Berenato, Rosa, Caporale, Marta, Antista, Maria, Niger, Monica, Smiroldo, Valeria, Murialdo, Roberto, Zaniboni, Alberto, Adamo, Vincenzo, Tomasello, Gianluca, Giordano, Monica, Petrelli, Fausto, Longarini, Raffaella, Cinieri, Saverio, Falcone, Alfredo, Zagonel, Vittorina, Di Bartolomeo, Maria, de Braud, Filippo
Publicat a JAMA Oncol (2019)